Forendo Pharma Ltd clinical trials
Acquired by Organon & Co., Dec 13, 2021 · source ↗
The registry lists 2 studies whose lead sponsor is Forendo Pharma Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 29, 2021.
Before and after it joined Organon & Co.
- First submitted before Forendo Pharma Ltd became part of Organon & Co.
- 2
- First submitted after Forendo Pharma Ltd became part of Organon & Co.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Forendo Pharma Ltd2 studies
Something wrong with this grouping? Tell us on the Organon & Co. page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Organon & Co. studies →
- A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet FormulationsCompletedNCT04686669Phase 1
Sponsor listed in the registry: Forendo Pharma Ltd · First submitted before Forendo Pharma Ltd became part of Organon & Co.
- A Study to Investigate the Safety, Tolerability, Food Effect, Pharmacokinetics and Pharmacodynamics of FOR-6219CompletedNCT03709420Phase 1
Sponsor listed in the registry: Forendo Pharma Ltd · First submitted before Forendo Pharma Ltd became part of Organon & Co.